[Financiación]
De interés para:
Para el sector salud
Resumen:
EIT Health is strengthening its support for high-potential, Micro, Small and Medium-sized enterprises (SME’s) by providing targeted funding through the Transformative Health Instrument (THI). The THI is designed to support high-potential European SMEs that aim to create significant impact in healthcare.
The THI offers up to €500,000 in grant funding in 2025 to SMEs, with the possibility of additional funding in 2026-28 for future research and development (R&D) projects that are co[1]funded through private capital investments in future equity rounds.
Beneficiaries of the THI are required to co-fund a minimum of 30% of the 2025 project. For subsequent projects in 2026-28, co-funding requirements will continue to apply, with rates varying based on each project’s start date. With this opportunity, EIT Health aims to support SMEs to activate private capital and propel their venture’s acceleration.
The application will be made through the EIT Health Application Platform. New applicants will need to register on the Application Platform.
